Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01334177
What this trial is testing

TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+38 more
University of Washington 13
Testing effectiveness (Phase 2)Study completedNCT01316757
What this trial is testing

Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+20 more
Fox Chase Cancer Center 24
Early research (Phase 1)UnknownNCT02761291
What this trial is testing

Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Chang Gung Memorial Hospital 18
Not applicableEnded earlyNCT00563862
What this trial is testing

Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)

Who this might be right for
Nasopharyngeal NeoplasmsCarcinoma, Squamous Cell
Hospital Authority, Hong Kong 465
Testing effectiveness (Phase 2)Study completedNCT04736810
What this trial is testing

Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Akeso 28
Large-scale testing (Phase 3)Study completedNCT03387774
What this trial is testing

Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients

Who this might be right for
Oral Mucositis (Ulcerative) Due to Radiation
Sun Yat-sen University 179
Not applicableStudy completedNCT02113423
What this trial is testing

Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancer Recurrent
Fujian Cancer Hospital 168
Not applicableUnknownNCT00364962
What this trial is testing

Treatment Result of KTP Laser Nasopharyngectomy in Recurrent NPC Patients

Who this might be right for
RecurrentNasopharyngeal Carcinoma
National Taiwan University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT04396886
What this trial is testing

Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC

Who this might be right for
Nasopharyngeal CarcinomaRecurrent CarcinomaMetastatic Cancer+1 more
The University of Hong Kong 38
Testing effectiveness (Phase 2)UnknownNCT00003182
What this trial is testing

Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
Hope Cancer Institute, Inc. 40
Not applicableUnknownNCT03942380
What this trial is testing

Cell-free Tumor DNA in Head and Neck Cancer Patients

Who this might be right for
Head and Neck CancerHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma+24 more
Christian von Buchwald 500
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Large-scale testing (Phase 3)UnknownNCT02434614
What this trial is testing

Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Wei Jiang 440
Testing effectiveness (Phase 2)Study completedNCT00630149
What this trial is testing

Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 35
Not applicableUnknownNCT02089204
What this trial is testing

Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Xuzhou Medical University 300
Not applicableUnknownNCT00941538
What this trial is testing

Cluster Randomized Controlled Screening Trial for NPC

Who this might be right for
Nasopharyngeal CancerScreeningMorality
Sun Yat-sen University 87,600
Not applicableNot Yet RecruitingNCT07399158
What this trial is testing

CROSSROAD: Treatment Regimen Switch - Re-induction Chemotherapy vs. Direct Radiotherapy in LANPC With Inadequate Response to Induction Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 223
Large-scale testing (Phase 3)Not Yet RecruitingNCT05717764
What this trial is testing

Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing Treatment

Who this might be right for
Recurrent Metastatic Nasopharyngeal Carcinoma
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 500
Early research (Phase 1)UnknownNCT05222009
What this trial is testing

G-CSF in Patients With Anti-PD-1-axis Therapy-resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Granulocyte Colony-Stimulating FactorPD-1 Inhibitor
Sun Yat-sen University 25
Not applicableUnknownNCT04764149
What this trial is testing

Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 801
Next Page